Lisata Therapeutics Competitors and Similar CompaniesClear all

Lisata Therapeutics's competitors and similar companies include Arrogene, Guardant Health, KEW and Oncompass.

	Lisata Therapeutics Lisata Therapeutics is a biopharmaceutical company providing platform technologies for solid tumors and other major diseases treatment.	Arrogene Arrogene is a development stage company that develops nano-biopolymers and related technologies for cancer therapeutics and diagnostics.	Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.	KEW KEW is a genomic profiling company specializing in cancer care.	Oncompass Oncompass is a health information company that helps oncologists and cancer patients to find and access cancer therapies.
Founding Date	Founding Date 2006	Founding Date 2007	Founding Date 2012	Founding Date 2011	Founding Date 2006
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Healthcare biotech healthtech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare biotech medical diagnostics oncology therapy	Tags Healthcare application software healthtech medical diagnostics oncology therapy
Locations	Locations Bernards, US HQ Sydney, AU Dublin, IE Osaka, JP Edinburgh, GB	Locations West Hollywood, US HQ	Locations Redwood City, US HQ	Locations Waltham, US HQ Newton, US	Locations Feusisberg, CH HQ
Employees	Employees 257% decrease	Employees N/A	Employees 1,7681% decrease	Employees 205% increase	Employees 284% increase
Valuation ($)	Valuation ($) 24 m	Valuation ($) N/A	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $170k (FY, 2024)	Revenue (est.) N/A	Revenue (est.) $982m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($16.6m) (FY, 2024)	Net income ($1m) (FY, 2015)	Net income ($416.3m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 750k (about 10 years ago)	Latest funding round N/A	Latest funding round $ 16.8m (over 11 years ago)	Latest funding round N/A
Total funding raised	Total funding raised N/A	Total funding raised $ 3.7m	Total funding raised $ 550m	Total funding raised $ 32.9m	Total funding raised N/A